Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Pancreatic carcinoma
ADR ID BADD_A03262
ADR Hierarchy
07      Gastrointestinal disorders
07.21      Malignant and unspecified neoplasms gastrointestinal NEC
07.21.09      Pancreatic neoplasms
07.21.09.002      Pancreatic carcinoma
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.13      Gastrointestinal neoplasms malignant and unspecified
16.13.10      Pancreatic neoplasms malignant (excl islet cell and carcinoid)
16.13.10.001      Pancreatic carcinoma
Description Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA). [MeSH]
MedDRA Code 10033609
MeSH ID D010190
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE) Not Available
Synonym
Cancer of head of pancreas | Cancer of head of pancreas non-resectable | Cancer of head of pancreas resectable | Cancer of pancreas (excl head) | Cancer of pancreas (excl head) non-resectable | Cancer of pancreas (excl head) resectable | Malignant neoplasm of body of pancreas | Malignant neoplasm of body of pancreas non-resectable | Malignant neoplasm of body of pancreas resectable | Malignant neoplasm of head of pancreas | Malignant neoplasm of head of pancreas non-resectable | Malignant neoplasm of head of pancreas resectable | Malignant neoplasm of other specified sites of pancreas | Malignant neoplasm of pancreas | Malignant neoplasm of pancreas non-resectable | Malignant neoplasm of pancreas resectable | Malignant neoplasm of pancreas, part unspecified | Malignant neoplasm of tail of pancreas | Malignant neoplasm of tail of pancreas non-resectable | Malignant neoplasm of tail of pancreas resectable | Pancreas cancer | Pancreas carcinoma | Pancreas carcinoma resectable | Pancreas neoplasm malignant | Pancreas neoplasm malignant non-resectable | Pancreas neoplasm malignant resectable | Pancreatic cancer | Pancreatic cancer non-resectable | Pancreatic cancer resectable | Pancreatic carcinoma | Pancreatic carcinoma non-resectable | Pancreatic carcinoma NOS | Pancreatic carcinoma resectable | Pancreatic Neoplasms | Neoplasm, Pancreatic | Pancreatic Neoplasm | Pancreas Neoplasms | Neoplasm, Pancreas | Neoplasms, Pancreas | Pancreas Neoplasm | Neoplasms, Pancreatic | Cancer of Pancreas | Pancreas Cancers | Pancreas Cancer | Cancer, Pancreas | Cancers, Pancreas | Pancreatic Cancer | Cancer, Pancreatic | Cancers, Pancreatic | Pancreatic Cancers | Cancer of the Pancreas
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01418Methotrexate--
BADD_D01533Naproxen0.000019%
BADD_D01601Olaparib0.000392%
BADD_D01614Omeprazole0.000007%
BADD_D01624Orlistat0.016966%
BADD_D01653Paclitaxel0.008786%
BADD_D01777Pioglitazone0.000300%
BADD_D01909Ramipril0.000186%
BADD_D01913Ranitidine0.011131%
BADD_D01933Ribavirin--
BADD_D01954Rivaroxaban--
BADD_D01992Saxagliptin0.001637%
BADD_D02006Selexipag0.000123%
BADD_D02029Sitagliptin0.005184%
BADD_D02100Sunitinib0.001477%
BADD_D02107Tafamidis0.001346%
BADD_D02246Tolvaptan0.000058%
BADD_D02257Trametinib0.000358%
BADD_D02331Valsartan0.000846%
BADD_D02375Water--
BADD_D02392Zoledronic acid--
BADD_D02412Octreotide0.000559%
BADD_D02436Atorvastatin--
BADD_D02442Magnesium oxide0.000182%
BADD_D02481Naldemedine0.000878%
BADD_D02487Baricitinib--
BADD_D02508Edaravone0.000538%
BADD_D02526Larotrectinib0.000336%
The 2th Page    First    Pre   2    Total 2 Pages